Diagnostic utility of CD117, CD133, SALL4, OCT4, TCL1 and glypican-3 in malignant germ cell tumors of the ovary

Journal of Obstetrics and Gynaecology Research

Volumn 38, Issue 5, 2012, Pages 841-848

  Trinh, Dat Tien ^a   Shibata, Kiyosumi ^a   Hirosawa, Tomoya ^a   Umezu, Tomokazu ^a   Mizuno, Mika ^a   Kajiyama, Hiroaki ^a   Kikkawa, Fumitaka ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

CD117; CD133; OCT4; Ovarian malignant germ cell tumor; SALL4; TCL1

Indexed keywords

AMINO TERMINAL TELOPEPTIDE; CD133 ANTIGEN; GLIAL FIBRILLARY ACIDIC PROTEIN; GLYPICAN; OCTAMER TRANSCRIPTION FACTOR 4; STEM CELL FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; DIAGNOSTIC PROCEDURE; DYSGERMINOMA; FEMALE; GERM CELL TUMOR; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OVARY; PROTEIN EXPRESSION; T CELL LEUKEMIA; TERATOMA;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD; DIAGNOSIS, DIFFERENTIAL; FEMALE; GLYCOPROTEINS; GLYPICANS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASMS, GERM CELL AND EMBRYONAL; OCTAMER TRANSCRIPTION FACTOR-3; OVARIAN NEOPLASMS; PEPTIDES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-KIT; SENSITIVITY AND SPECIFICITY; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84861065210     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2011.01798.x     Document Type: Article

References (29)

1. Liu A, Cheng L, Du J et al. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors. Am J Surg Pathol 2010; 34: 697-706.
2. Cao D, Guo S, Allan RW et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol 2009; 33: 894-904.
3. Pectasides D, Pectasides E, Kassanos D. Germ cell tumors of the ovary. Cancer Treat Rev 2008; 34: 427-441.
4. Quirk JT, Natarajan N. Ovarian cancer incidence in the United States, 1992-1999. Gynecol Oncol 2005; 97: 519-523. (Pubitemid 40614898)
5. Ulbright TM. Germ cell tumors of the gonads: A selectivereview emphasizing problems in differential diagnosis, newly appreciated, and controversial issues. Mod Pathol 2005; 18 (Suppl 2): S61-S79. (Pubitemid 40192565)
6. Zynger DL, Everton MJ, Dimov ND et al. Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Am J Clin Pathol 2008; 130: 224-230.
7. Chang MC, Vargas SO, Hornick JL et al. Embryonic stem cell transcription factors and D2-40 (Podoplanin) as diagnosticimmunohistochemical markers in ovarian germ cell tumors. Int J Gynecol Pathol 2009; 28: 347-355.
8. Baker P, Oliva E. A practical approach to intraoperative consultation in gynecological pathology. Int J Gynecol Pathol 2008; 27: 353-365.
9. Yoshida M, Koshiyama M, Konishi M et al. Ovarian dysgerminoma showing high serum levels and positive immunostainingof placental alkaline phosphatase and neuronspecific enolase associated with elevation of serum prolactin level. Eur J Obstet Gynecol Reprod Biol 1998; 81: 123-128. (Pubitemid 28464456)
10. Cohen MB, Mulchahey KM, Molnar JJ. Ovarian endodermal sinus tumor with intestinal differentiation. Cancer 1986; 57: 1580-1583. (Pubitemid 16135607)
11. Orazi A, Neiman RS, Ulbright TM, Heerema NA, John K, Nichols CR. Hematopoietic precursor cells within the yolk sac tumor component are the source of secondary hematopoietic malignancies in patients with mediastinal germ cell tumors. Cancer 1993; 71: 3873-3881. (Pubitemid 23172964)
12. Devouassoux-Shisheboran M, Schammel DP, Tavassoli FA. Ovarian hepatoid yolk sac tumours: Morphological, immunohistochemical and ultrastructural features. Histopathology1999; 34: 462-469. (Pubitemid 29244172)
13. Metzman RA, Warhol MJ, Gee B, Roth J. Polysialic acid as a marker of both immature and mature neural tissue in humanteratomas. Mod Pathol 1991; 4: 491-497.
14. Lau SK, Weiss LM, Chu PG. TCL1 protein expression in testicular germ cell tumors. Am J Clin Pathol 2010; 133: 762-766.
15. Tavassoli FA, Devilee P (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Female Genital Tract. Lyon: IARC Press, 2003; 163-179.
16. Wei W, Qing T, Ye X et al. Primordial germ cell specificationfrom embryonic stem cells. PLoS ONE 2008; 3: e4013.
17. Sever M, Jones TD, Roth LM et al. Expression of CD117 (C-KIT) receptor in dysgerminoma of the ovary: Diagnostic and therapeutic implications. Mod Pathol 2005; 18: 1411-1416. (Pubitemid 41509394)
18. Medinger M, Kleinschmidt M, Mross K et al. C-kit (CD117) expression in human tumors and its prognostic value: An immunohistochemical analysis. Pathol Oncol Res 2010; 16:295-301.
19. Ellenson LH, Pirog EC. The female genital tract. In: Kumar V (ed.). Robbins and Cotran Pathologic Basis of Disease, 8th edn. Tokyo: Saunders/Elsevier, 2010; 1005-1063.
20. Kitamura H, Okudela K, Yazawa T, Sato H, Shimoyamada H. Cancer stem cell: Implication in cancer biology and therapy with special reference to lung cancer. Lung Cancer 2009; 66: 275-281.
21. O'Brien CA, Pollett A, Gallinger S, Dick JE. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445: 106-110. (Pubitemid 46067310)
22. Suetsugu A, Nagaki M, Aoki H, Motohashi T, Kunisada T, Moriwaki H. Characterization of CD133+ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun 2006; 351: 820-824. (Pubitemid 44715858)
23. Ricci-Vitiani L, Lombardi DG, Pilozzi E et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007; 445: 111-115. (Pubitemid 46067311)
24. Ferrandina G, Martineli E, Petrillo M et al. CD133 antigen expression in ovarian cancer. BMC Cancer 2009; 9: 221.
25. Suzuki S, Terauchi M, Umezu T et al. Identification and characterization of cancer stem cells in ovarian yolk sac tumors. Cancer Sci 2010; 101: 2179-2185.
26. Ayhan A, Taskiran C, Bozdag G et al. Endodermal sinus tumor of the ovary: The Hacettepe University experience. Eur J Obstet Gynecol Reprod Biol 2005; 123: 230-234. (Pubitemid 41728371)
27. Wang F, Liu A, Peng Y et al. Diagnostic utility of SALL4 in extragonadal yolk sac tumors-An immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am J Surg Pathol 2009; 33: 1529-1539.
28. Cheng L, Sung MT, Cossu-Rocca P et al. OCT4: Biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 2007; 211: 1-9. (Pubitemid 46092024)
29. Abiko K, Mandai M, Hamanishi J et al. OCT4 expression in immature teratoma of the ovary: Relevance to histologic grade and degree of differentiation. Am J Surg Pathol 2010; 34:1842-1848.